Market Access: The Latest Hurdle for Treating Alzheimer’s and Dementia
When you think of NAPA your mind might conjure up tasting great wine or touring through the beautiful countryside north of San Francisco. However, the
When you think of NAPA your mind might conjure up tasting great wine or touring through the beautiful countryside north of San Francisco. However, the
There has been an encouraging trend in the life science industry, a growing emphasis on rare diseases. Where as little as 20 years ago, there
So you read our previous post or checked out our podcast on biomarkers? Great! If not no problem, you can catch up, please click here
Efficiency is the name of the game these days in the life sciences. With drug development being an arduous and costly endeavor, companies are looking
With inflation rapidly accelerating, worries persist that the economy is headed for a recession. Big Tech has already either frozen or drastically curtailed hiring, leaving
With the advent of legalized marijuana in some states, rates of a relatively little known condition called cannabis use disorder (CUD) have risen. According to
Partnering with stakeholder and advocacy groups operates as a kind of economic signaling borrowing from Game Theory. Signaling in economics is when a sender transmits
In an industry as competitive as life sciences, companies have to make decisions in the face of uncertainty and incomplete information. In our previous post
A study of the mathematical models of conflict and cooperation between intelligent rationale decision makers, Game Theory provides a useful lens to analyze any industry.
A recent Financial Times article highlighted an interesting disparity between the U.S and Europe: despite having roughly similar numbers of top academic life science institutions,